Lava Therapeutics is a biotech company that develops T-cell engagers for the therapy of solid tumors and hematologic malignancies. It provides immune-oncology biopharmaceuticals delivering the primary targeted treatment in combination with immune recruiting and activating functionality.
Revenue (FY, 2020)
Net income (FY, 2020)
EBIT (FY, 2020)
Market capitalization (21-Sept-2021)
Closing stock price (21-Sept-2021)
|Company Name||Date||Deal Size|
|Lava Therapeutics, Inc.|
Lava Therapeutics has 77 Twitter Followers. The number of followers has increased 2.7% month over month and increased 23.9% quarter over quarter
When was Lava Therapeutics founded?
Lava Therapeutics was founded in 2016.
Who are Lava Therapeutics key executives?
Lava Therapeutics's key executives are Steve Hurly, Ton Adang and Hans van der Vliet.
How many employees does Lava Therapeutics have?
Lava Therapeutics has 28 employees.
What is Lava Therapeutics revenue?
Latest Lava Therapeutics annual revenue is €3.2 m.
What is Lava Therapeutics revenue per employee?
Latest Lava Therapeutics revenue per employee is €113.8 k.
Who are Lava Therapeutics competitors?
Competitors of Lava Therapeutics include Viosera Therapeutics, Shanghai Henlius Biotech and Cellectar Biosciences.
Where is Lava Therapeutics headquarters?
Lava Therapeutics headquarters is located at Yalelaan 60, Utrecht.
Where are Lava Therapeutics offices?
Lava Therapeutics has offices in Utrecht and Philadelphia.
How many offices does Lava Therapeutics have?
Lava Therapeutics has 2 offices.
Receive alerts for 300+ data fields across thousands of companies